MedTrace Logo

Methodology for Developing an Occlusal Appliance With CBD Active Carrier

NCT04775030 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-03-01

No results posted yet for this study

Summary

Evaluation of the efficacy of the occlusal appliance with active cannabidiol (CBD) molecules in TMD patients

Conditions

  • Temporomandibular Disorder
  • Myofascial Pain
  • Cannabis
  • Electromyography
  • Occlusal Appliance
  • CBD

Interventions

DRUG

CBD occlusal appliance

Occlusal appliance manufactured with CBD molecules released from material to patients oral cavity during sleep time

DEVICE

Acrylic resin occlusal appliance

Acrylic resin occlusal appliance during sleep time

Sponsors & Collaborators

  • Medical University of Silesia

    lead OTHER

Principal Investigators

  • Magdalena Antonowicz, Adiunct · Technical University of Silesia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-01-01
Completion
2023-01-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04775030 on ClinicalTrials.gov